Michael Menzel

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

JCO precision oncology

The journal of pathology. Clinical research

Nature reviews. Clinical oncology

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Budczies, Daniel N Kazdal, Michael Menzel, Susanne Beck, Klaus Kluck, Christian Altbürger, Constantin Schwab, Michael Allgäuer, Aysel Ahadova, Matthias Kloor, Peter Schirmacher, Solange Peters, Alwin Krämer, Petros Christopoulos, Albrecht Stenzinger
Tumour mutational burden: clinical utility, challenges and emerging improvements. Nature reviews. Clinical oncology (2024)
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 10 (2) (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Michael Menzel, Martina Kirchner, Klaus Kluck, Markus Ball, Susanne Beck, Michael Allgäuer, Christin Assmann, Johannes Schnorbach, Anna-Lena Volckmar, Timothy Kwang Yong Tay, Hannah Goldschmid, Daniel Sw Tan, Michael Thomas, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger, Petros Christopoulos
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors. The journal of pathology. Clinical research 10 (2) (2024)
Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, Sabine Merkelbach-Bruse, Janna Siemanowski, Eva-Maria Mayr, Sylvia Herold, Karsten Kleo, Lukas C Heukamp, Eva Maria Willing, Michael Menzel, Ulrich Lehmann, Stephan Bartels, Shounak Chakraborty, Gustavo Baretton, Melanie C Demes, Claudia Döring, Daniel N Kazdal, Jan Budczies, Roland Rad, Peter Wild, Yann Christinat, Thomas A McKee, Peter Schirmacher, David Horst, Reinhard Buttner, Albrecht Stenzinger, Jalid Sehouli, Claudia Vollbrecht, Michael Hummel, Elena I Braicu, Wilko Weichert, null null
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer. JCO precision oncology 8 (2024)
Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger, Jan Budczies
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. Cell death discovery 9 (1) (2023)
Michael Menzel, Stephan Ossowski, Sebastian Kral, Patrick Metzger, Peter Horak, Ralf Marienfeld, Melanie Börries, Steffen Wolter, Markus Ball, Olaf Neumann, Sorin Armeanu-Ebinger, Christopher Schroeder, Uta Matysiak, Hannah Goldschmid, Vincent Schipperges, Axel Fürstberger, Michael Allgäuer, Timo Eberhardt, Jakob Niewöhner, Andreas Blaumeiser, Carolin Ploeger, Tobias Bernd Haack, Timothy Kwang Yong Tay, Olga Kelemen, Thomas Pauli, Martina Kirchner, Klaus Kluck, Alexander Ott, Marcus Renner, Jakob Admard, Axel Gschwind, Silke Lassmann, Hans Kestler, Falko Fend, Anna Lena Illert, Martin Werner, Peter Möller, Thomas Theodor Werner Seufferlein, Nisar Malek, Peter Schirmacher, Stefan Fröhling, Daniel N Kazdal, Jan Budczies, Albrecht Stenzinger
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients. NPJ precision oncology 7 (1) (2023)
Adrian Kovač, Csaba Miskey, Michael Menzel, Esther Grueso, Andreas Gogol-Döring, Zoltán Ivics
RNA-guided retargeting of Sleeping Beauty transposition in human cells. eLife 9 (2020)

Michael Menzel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Menzel